Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity

By sjmartinez • September 20, 2024

Mechanick JI, Butsch WS, Christensen SM, Hamdy O, Li Z, Prado CM, Heymsfield SB. Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity. Obes Rev. 2024 Sep 19:e13841. doi: 10.1111/obr.13841. Epub ahead of print. PMID: 39295512.

Tags: Clinical Nutrition, GLP‐1 receptor agonist, Hospitalist, muscle loss, Nutrition, Publications, resistance training, Veterans Administration

Hypertension Management in Women With a Multidisciplinary Approach

Nobakht N, Afshar Y, Vaseghi M, Li Z, Donangelo I, Lavretsky H, Mok T, Han CS, Nicholas SB. Hypertension Management in Women With a Multidisciplinary[...]

Coffee and tea consumption and the risk of head and neck cancer: An updated pooled analysis in the International Head and Neck Cancer Epidemiology Consortium

Nguyen T, Koric A, Chang CE, Barul C, Radoi L, Serraino D, Purdue MP, Kelsey KT, McClean MD, Negri E, Edefonti V, Moysich K, Zhang[...]

The Effects of a Grape Seed Procyanidin Extract on Cytochrome P450 3A4 Activity and Inflammatory Mediators in the Lungs of Heavy Active and Former Smokers

Xue B, Qualls C, Lanthiez A, Lu QY, Yang J, Lee RP, Neis P, Mao JT. The Effects of a Grape Seed Procyanidin Extract on[...]